Genetics
Had the opportunity to attend ASCO last week with a few goals in mind: Get updates on current trends in oncology management as oncologists are common clients of pathologists and laboratories. Spend some time in the exhibit area to see how...
Thurs, 4th June | UK 4pm BST | EU 5pm CEST | USA 11am EST, 10am CDT | Register here Join our guest speaker Professor Manuel Salto-Tellez, Clinical Professor at Queen’s University, Belfast as he...
June 4-6, 2015 Booth # 2P Hyatt Regency Savannah, Georgia See the new capabilities of the GenASIs Cytogenetics Suite for Karyotyping and FISH Solutions for Any Sized Lab Superior solutions for FISH and Karyotyping Infinite...
Two new investors, Cambridge Innovative Capital and Scottish Equity Partners join existing investors Albion Ventures and UCLB The investment enables the launch of the ROCA® test in US and UK in 2015, as well as the establishment of a...
Accuracy of HER2 Testing in Gastric Cancer
- Anatomic Pathology
- Business
- Clinical Laboratories
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Genetics
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Medical Research
- Pathology News
- Patient Advocacy
- Science
- Standards and Guidelines
- Training
- Vendor products
- Web/Tech
- Webinars
- Whole slide
With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab...
SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced that...
